Bone Biologics Corporation

US$0.33As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:BBLGHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (72.32%)
Div yield —
ROE (47.49%)
Biotechnology
Beta (5Y) 0.90
PE TTM —
TSR TTM (84.35%)
Mkt cap US$1.130M
ROIC (31.46%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.391
17.37%
(76.61%)
Hold 10|12|10|3|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
14.48%
14.82%
29.46%
29.05%
Revenue$M
0.054
0.056
0.057
0.058
6.63%
10.18%
8.56%
5.69%
Peers (US$1.130M)
Cap (US$)
PE
1.218M
—
Capital
TTM
5Y
10Y
Leveragex
2.546
(0.020)
(0.021)
EBIT/Intx
6.113
0.091
0.095
Own earn%
82.60
42.89
67.40
Sh yield%
34.54
29.04
28.05
Owners
Insiders/Inst%
0.62
57.31
Short interest%
2.85
SBC / revenue%
5.70
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
15–22
$1 testx
0.0
Incr. ROIC%
0